Anton M. Safonov

Oncology
1101 Hempstead Tpke
Uniondale, NY 11553

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 37 publications

Oral Estrogen Receptor Degraders Compared to Standard Endocrine Therapy in Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer: A Systematic Review and Meta-Analysis.

Oral Estrogen Receptor Degraders Compared to Standard Endocrine Therapy in Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer: A Systematic Review and Meta-Analysis.

Journal: Cancers
Published: May 26, 2026

Cancer type-specific variation in patterns of driver alterations across 50,000 tumors.

Cancer type-specific variation in patterns of driver alterations across 50,000 tumors.

Journal: Cancer cell
Published: April 19, 2026

Real-world cell-free circulating tumor DNA (ctDNA) analysis identifies CDK4/6 inhibitor resistance and tumor evolution in HR+ advanced breast cancer.

Real-world cell-free circulating tumor DNA (ctDNA) analysis identifies CDK4/6 inhibitor resistance and tumor evolution in HR+ advanced breast cancer.

Journal: NPJ breast cancer
Published: February 17, 2026

Publisher Correction: APOBEC3 mutagenesis drives therapy resistance in breast cancer.

Publisher Correction: APOBEC3 mutagenesis drives therapy resistance in breast cancer.

Journal: Nature genetics
Published: December 12, 2025

Sequential use of PI3K/AKT/mTOR pathway inhibitors alpelisib and everolimus in patients with hormone receptor-positive metastatic breast cancer.

Sequential use of PI3K/AKT/mTOR pathway inhibitors alpelisib and everolimus in patients with hormone receptor-positive metastatic breast cancer.

Journal: Breast cancer research : BCR
Published: August 17, 2025

Monitoring of circulating tumor DNA in patients with stage II-III breast cancer treated with neoadjuvant chemotherapy.

Monitoring of circulating tumor DNA in patients with stage II-III breast cancer treated with neoadjuvant chemotherapy.

Journal: NPJ breast cancer
Published: July 04, 2025

Impact of Clonal Hematopoiesis on Solid Tumor Progression Following Radiation Therapy.

Impact of Clonal Hematopoiesis on Solid Tumor Progression Following Radiation Therapy.

Journal: JCO precision oncology
Published: April 18, 2025

Integration of Next Generation Sequencing Data to Inform Survival Prediction of Patients with Spine Metastasis.

Integration of Next Generation Sequencing Data to Inform Survival Prediction of Patients with Spine Metastasis.

Journal: Cancers
Published: April 12, 2025

Long-term breast cancer response to CDK4/6 inhibition defined by TP53-mediated geroconversion.

Long-term breast cancer response to CDK4/6 inhibition defined by TP53-mediated geroconversion.

Journal: Cancer cell
Published: November 12, 2024

Tumor suppressor heterozygosity and homologous recombination deficiency mediate resistance to front-line therapy in breast cancer.

Tumor suppressor heterozygosity and homologous recombination deficiency mediate resistance to front-line therapy in breast cancer.

Journal: bioRxiv : the preprint server for biology
Published: September 10, 2024

APOBEC3 mutagenesis drives therapy resistance in breast cancer.

APOBEC3 mutagenesis drives therapy resistance in breast cancer.

Journal: bioRxiv : the preprint server for biology
Published: May 15, 2024

Predictors of Response to CDK4/6i Retrial After Prior CDK4/6i Failure in ER+ Metastatic Breast Cancer.

Predictors of Response to CDK4/6i Retrial After Prior CDK4/6i Failure in ER+ Metastatic Breast Cancer.

Journal: Research square
Published: May 15, 2024
Showing 1-12 of 37

Last Updated: 09/26/2026